Matthew H Wilson Selected Research

Type A Cystinuria

1/2020

CRISPR/Cas9 engineering of albino cystinuria Type A mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Matthew H Wilson Research Topics

Disease

10	Neoplasms (Cancer) 01/2022 - 10/2009
3	Kidney Diseases (Kidney Disease) 01/2022 - 01/2017
3	Fibrosis (Cirrhosis) 01/2020 - 12/2012
2	Cystinuria 01/2022 - 01/2019
1	Neoplasm Metastasis (Metastasis) 01/2022
1	Acute Kidney Injury (Acute Renal Failure) 01/2022
1	Adenocarcinoma of Lung 01/2022
1	Carcinogenesis 01/2022
1	Type A Cystinuria 01/2020
1	Albinism 01/2020
1	Urinary Bladder Calculi (Bladder Calculi) 01/2020
1	Sarcoma (Soft Tissue Sarcoma) 01/2020
1	Nephrolithiasis 01/2019
1	Chronic Renal Insufficiency 01/2019
1	Hematologic Neoplasms (Hematological Malignancy) 08/2018
1	Hypoxia (Hypoxemia) 01/2018
1	Juvenile Myelomonocytic Leukemia 03/2016
1	Ureteral Obstruction 05/2015
1	Melanoma (Melanoma, Malignant) 01/2015
1	Experimental Melanoma 01/2015
1	Philadelphia Chromosome 09/2014
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 09/2014
1	Chronic Disease (Chronic Diseases) 12/2012
1	Persistent Infection 12/2011
1	Brain Neoplasms (Brain Tumor) 12/2011
1	Lymphoma (Lymphomas) 12/2011
1	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 09/2002

Drug/Important Bio-Agent (IBA)

6	Chimeric Antigen ReceptorsIBA 08/2018 - 12/2011
3	LigandsIBA 01/2022 - 09/2014
2	IntegrinsIBA 01/2022 - 01/2020
2	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 01/2018
2	ErbB Receptors (EGF Receptor)IBA 01/2020 - 12/2011
2	Cystine (L-Cystine)IBA 01/2020 - 01/2019
2	Sirolimus (Rapamycin)FDA Link 11/2012 - 12/2011
1	Dinoprostone (PGE2)FDA Link 01/2022
1	AgarIBA 01/2022
1	ProstaglandinsIBA 01/2022
1	MafB Transcription FactorIBA 01/2022
1	CarcinogensIBA 01/2022
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 01/2022
1	Glutamine (L-Glutamine)FDA Link 01/2021
1	DNA (Deoxyribonucleic Acid)IBA 01/2020
1	CollagenIBA 01/2020
1	DNA-Binding Proteins (DNA Binding Protein)IBA 01/2020
1	Nuclear Proteins (Protein, Nuclear)IBA 01/2020
1	RNA (Ribonucleic Acid)IBA 01/2020
1	Monophenol Monooxygenase (Tyrosinase)IBA 01/2020
1	Glutathione (Reduced Glutathione)IBA 01/2019
1	Amino Acids FDA Link 01/2019
1	CreatinineIBA 01/2019
1	Cisplatin (Platino)FDA LinkGeneric 01/2018
1	cadherin 5IBA 05/2015
1	Insulin (Novolin)FDA Link 05/2015
1	Interleukin-12 (IL 12)IBA 01/2015
1	LuciferasesIBA 01/2015
1	OvalbuminIBA 01/2015
1	Interleukin-12 Subunit p35IBA 01/2015
1	N(1)-methyl-2-lysergic acid diethylamide (MIL)IBA 01/2015
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 09/2014
1	Interleukin-2 (IL2)IBA 09/2014
1	CD19-specific chimeric antigen receptorIBA 09/2014
1	Tyrosine Kinase InhibitorsIBA 09/2014
1	Glutathione Transferase (Glutathione S-Transferase)IBA 12/2012
1	IsoenzymesIBA 12/2012
1	4-hydroxy-2-nonenal (4-hydroxynonenal)IBA 12/2012
1	Neoplasm Antigens (Tumor Antigens)IBA 11/2012
1	AntigensIBA 12/2011
1	Viral AntigensIBA 12/2011
1	MTOR InhibitorsIBA 12/2011
1	TransposasesIBA 04/2010

Therapy/Procedure

8	Therapeutics 01/2022 - 10/2009
3	Immunotherapy 03/2018 - 12/2011
1	Drug Therapy (Chemotherapy) 09/2002